|
|
(Larger Image)
|
Biotech Investing: Every Investor's Guide
by James D. Mccamant, Jim McCamant
Product Group: Book
Publisher: Basic Books (2002-06-15)
ISBN: 0738205095
EAN: 9780738205090
Dewey Decimal #: 332.6322
Hardcover: 224 pages
Edition: 1st
Release Date: 2002-06-04
SKU: 90308000237
Condition: Fine
Comments: 0738205095 New, never read, may have minor wear on cover.
|
Editorial Reviews
|
Product Description
Biotechnology is indisputably one of the fastest-growing and most promising industries. Virtually immune to swings in the economic cycles, biotech stocks continue to perform steadily as high-tech stocks lose their steam.In Biotech Investing, Jim McCamant offers proven strategies and savvy advice on how to capitalize on the unprecedented opportunities in this high-potential sector. Written by a recognized authority, this book dissects biotech business models from start-up to IPO and discusses in detail the most important factors that affect biotech research. Comprehensive in scope, it looks at the best and worst biotech contenders, discusses all the most newsworthy developments in the field, and shows how they translate into business success or failure. It outlines simple criteria for choosing the best biotech stocks and for understanding the sometimes complicated dynamics of this sector.
|
Customer Reviews
|
Science good, investment insight bad
Rating  (1)
Date: 2004-05-19
2 out of 2 customers found this reveiw helpful
Disappointing. I guess this book is one example where the cover says it all; next time I see a book on Biotech investing, I want to see a dollar sign on the jacket.
Sure, I got the biotech bit, but where was the insight into investing. Nothing really hit me. I started reading the book not knowing how to invest in biotech; I ended the same way.On a positive note, I did like the writing style.
|
|
Excellent Advice!
Rating  (5)
Date: 2002-11-01
0 out of 4 customers found this reveiw helpful
WOW! Such a dense topic, so carefully written. I am the wiser for this book. Thank you for presenting this so clearly.
|
|
Guide, but not an *Investors* guide
Rating  (3)
Date: 2002-10-08
6 out of 6 customers found this reveiw helpful
I picked up this book with two kinds of expectations. One that McCamant would give me the "lay of the land" of the Biotech space, the competing markets and the key companies. The other, that he would provide deep insight (a la Peter Lynch) on an investment method. On the first count, the book does a reasonable job. On the second count, it is very disappointing. Most of the investment rules are obvious and generic. The investment web links are outdated.
|
|
|
|
|